Kazia Therapeutics Cash from Financing (TTM) Analysis

Kazia Therapeutics Ltd (KZIA)

0.355 0.00 (0.00%) USD | NASDAQ | Apr 30, 09:45

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2009. Upgrade now.

Date	Value
December 31, 2023	7.850M
June 30, 2023	8.600M
December 31, 2022	9.364M
June 30, 2020	8.074M
December 31, 2019	2.555M
June 30, 2019	2.736M
December 31, 2018	2.736M
June 30, 2018	0.00
December 31, 2017	-0.0003M
June 30, 2017	-0.0135M
December 31, 2016	-0.013M
June 30, 2016	0.5632M
December 31, 2015	31.92M

Date	Value
June 30, 2015	37.41M
December 31, 2014	6.050M
June 30, 2014	5.101M
December 31, 2013	8.092M
June 30, 2013	2.990M
December 31, 2012	1.188M
June 30, 2012	1.765M
December 31, 2011	1.388M
June 30, 2011	0.8109M
December 31, 2010	0.00
June 30, 2010	0.00
December 31, 2009	1.979M
June 30, 2009	7.974M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

2.555M

Minimum

Dec 2019

9.364M

Maximum

Dec 2022

6.530M

Average

7.962M

Median

Cash from Financing (TTM) Benchmarks